NeuroOne – The Medical Device Company That Has Created A Product That Could Monitor And Treat At The Same Time

Dave Rosa, President & CEO of NeuroOne (NASDAQ:NMTC), was recently a guest on Benzinga's All-Access.

NeuroOne is a medical device company that designs and manufactures high-definition, minimally invasive thin film electrodes used for intracranial monitoring and ablation. The devices diagnose and treat several neurological conditions like epilepsy and Parkinson's Disease. They are implanted inside the skull to record brain activity. That data helps surgeons better locate and remove the brain tissue causing issues without impacting the rest of the brain. 

The company also has a minimally invasive device that can be implanted in the spine, aiming to treat back pain.

Learn more here:

Featured photo by Milad Fakurian on Unsplash.

This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: BiotechInterviewGeneralBenzinga All AccessNeuroOne Medical Technologies Corp.Public Company Sponsored